Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience

Cell Transplantation

Volumn 22, Issue 12, 2013, Pages 2267-2277

  Wang, Dandan ^a   Zhang, Huayong ^a   Liang, Jun ^a   Li, Xia ^a   Feng, Xuebing ^a   Wang, Hong ^a   Hua, Bingzhu ^a   Liu, Bujun ^a   Lu, Liwei ^b   Gilkeson, Gary S ^c   Silver, Richard M ^c   Chen, Wanjun ^d   Shi, Songtao ^e   Sun, Lingyun ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Clinical remission; Lupus erythematosus; Mesenchymal stem cells (MSCs); Transplantation

Indexed keywords

ALBUMIN; ASCORBIC ACID; AUTOANTIBODY; AZATHIOPRINE; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; DNA ANTIBODY; GLYCEROL 2 PHOSPHATE; IMMUNOGLOBULIN; INDOMETACIN; INSULIN; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTETATE TECHNETIUM TC 99M; PREDNISONE; RITUXIMAB; TACROLIMUS; THALIDOMIDE; TUBERCULOSTATIC AGENT; VINCRISTINE;

ACUTE GASTROENTERITIS; ADOLESCENT; ADULT; ADVERSE OUTCOME; AGRANULOCYTOSIS; ALLOGENEIC STEM CELL TRANSPLANTATION; APHERESIS; ARTICLE; BONE MARROW; CAUSE OF DEATH; CELL CULTURE; CHILD; CORTICOSTEROID THERAPY; CULTURE MEDIUM; DIARRHEA; DISEASE ACTIVITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; FRACTURE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HERPES SIMPLEX; HUMAN; HYPOPROTEINEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LUNG EMBOLISM; LUNG INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MYCOSIS; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEINURIA; RELAPSE; REMISSION; SCORING SYSTEM; SLEDAI; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UMBILICAL CORD;

MUS;

ADOLESCENT; ADULT; AUTOANTIBODIES; BONE MARROW CELLS; CHILD; COMPLEMENT SYSTEM PROTEINS; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; RECURRENCE; SERUM ALBUMIN; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; UMBILICAL CORD; YOUNG ADULT;

EID: 84879160785     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911x582769c     Document Type: Article

References (35)

1. Bombardier, C.; Gladman, D. D.; Urowitz, M. B.; Caron, D.; Chang, C. H. Derivation of the SLEDAI: A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 35:630-640; 1992.
2. Burt, R. K.; Traynor, A.; Statkute, L.; Barr, W. G.; Rosa, R.; Schroeder, J.; Verda, L.; Krosnjar, N.; Quigley, K.; Yaung, K.; Villa, M.; Takahashi, M.; Jovanovic, B.; Oyama, Y. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295:527-535; 2006.
3. Carrion, F.; Nova, E.; Ruiz, C.; Diaz, F.; Inostroza, C.; Rojo, D.; Monckeberg, G.; Figueroa, F. E. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 19:317-322; 2010.
4. Conget, P. A.; Minguell, J. J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J. Cell. Physiol. 181:67-73; 1999.
5. Crow, M. K. Developments in the clinical understanding of lupus. Arthritis Res. Ther. 11:245; 2009.
6. El-Badri, N. S.; Hakki, A.; Ferrari, A.; Shamekh, R.; Good, R. A. Autoimmune disease: Is it a disorder of the microenvironment? Immunol. Res. 41:79-86; 2008.
7. Fan, L.; Lin, C.; Zhuo, S.; Chen, L.; Liu, N.; Luo, Y.; Fang, J.; Huang, Z.; Lin, Y.; Chen, J. Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction. Eur. J. Heart Fail. 11:1023-1030; 2009.
8. Gu, Z.; Akiyama, K.; Ma, X.; Zhang, H.; Feng, X.; Yao, G.; Hou, Y.; Lu, L.; Gilkeson, G. S.; Silver, R. M.; Zeng, X.; Shi, S.; Sun, L. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19:1502-1514; 2010.
9. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf, R. K.; Schulman, S. P.; Gerstenblith, G.; Demaria, A. N.; Denktas, A. E.; Gammon, R. S.; Hermiller, J. B.; Reisman, M. A. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54:2277-2286; 2009.
10. Houssiau, F. A.; Ginzler, E. M. Current treatment of lupus nephritis. Lupus 17:426-430; 2008.
11. Jayne, D.; Passweg, J.; Marmont, A.; Farge, D.; Zhao, X.; Arnold, R.; Hiepe, F.; Lisukov, I.; Musso, M.; Ou-Yang, J.; Marsh, J.; Wulffraat, N.; Besalduch, J.; Bingham, S. J.; Emery, P.; Brune, M.; Fassas, A.; Faulkner, L.; Ferster, A.; Fiehn, C.; Fouillard, L.; Geromin, A.; Greinix, H.; Rabusin, M.; Saccardi, R.; Schneider, P.; Zintl, F.; Gratwohl, A.; Tyndall, A. Autologous stem cell transplantation for systemic lupus erythematosus. Lupus 13:168-176; 2004.
12. Jiang, X. X.; Zhang, Y.; Liu, B.; Zhang, S. X.; Wu, Y.; Yu, X. D.; Mao, N. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120-4126; 2005.
13. Karim, M. Y.; Pisoni, C. N.; Khamashta, M. A. Update on immunotherapy for systemic lupus erythematosus-What's hot and what's not. Rheumatology 48:332-341; 2009.
14. Katsifis, G. E.; Tzioufas, A. G. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus 13:673-678; 2004.
15. Kestendjieva, S.; Kyurkchiev, D.; Tsvetkova, G.; Mehandjiev, T.; Dimitrov, A.; Nikolov, A.; Kyurkchiev, S. Characterization of mesenchymal stem cells isolated from the human umbilical cord. Cell Biol. Int. 32:724-732; 2008.
16. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579-1586; 2008.
17. Lee, J. S.; Hong, J. M.; Moon, G. J.; Lee, P. H.; Ahn, Y. H.; Bang, O. Y. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28:1099-1106; 2010.
18. Li, K.; Han, Q.; Yan, X.; Liao, L.; Zhao, R. C. Not a process of simple vicariousness, the differentiation of human adipose-derived mesenchymal stem cells to renal tubular epithelial cells plays an important role in acute kidney injury repairing. Stem Cells Dev. 19:1267-1275; 2010.
19. Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Lu, L.; Shi, S.; Hou, Y.; Zeng, X.; Gilkeson, G. S.; Sun, L. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: A pilot clinical study. Ann. Rheum. Dis. 69:1423-1429; 2010.
20. Looney, R. J.; Anolik, J. H.; Campbell, D.; Felgar, R. E.; Young, F.; Arend, L. J.; Sloand, J. A.; Rosenblatt, J.; Sanz, I. B-cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose escalation trial of rituximab. Arthritis Rheum. 50:2580-2589; 2004.
21. Merrill, J. T.; Neuwelt, C. M.; Wallace, D. J.; Shanahan, J. C.; Latinis, K. M.; Oates, J. C.; Utset, T. O.; Gordon, C.; Isenberg, D. A.; Hsieh, H. J.; Zhang, D.; Brunetta, P. G. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 62:222-233; 2010.
22. Nauta, A. J.; Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506; 2007.
23. Navarro-Zarza, J. E.; Alvarez-Hernández, E.; Casasola-Vargas, J. C. Prevalence of community-acquired and nosocomial infections in hospitalized patients with systemic lupus erythematosus. Lupus 19:43-48; 2010.
24. Nie, Y.; Lau, C. S.; Lie, A. K.; Chan, G.; Mok, M. Defective phenotype of mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 19:850-859; 2010.
25. Petri, M. Systemic lupus erythematosus: 2006 update. J. Clin. Rheumatol. 12:37-40; 2006.
26. Ruiz-Irastorza, G.; Olivares, N.; Ruiz-Arruza, I.; Martinez-Berriotxoa, A.; Egurbide, M. V.; Aguirre, C. Predictors of major infections in systemic lupus erythematosus. Arthritis Res. Ther. 11:R109; 2009.
27. Sanchez-Ramos, J.; Song, S.; Cardozo-Peleza, F.; Hazzi, C.; Stedeford, T.; Willing, A.; Freeman, T. B.; Saporta, S.; Janssen, W.; Patel, N.; Cooper, D. R.; Sanberg, P. R. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp. Neurol. 164:247-256; 2000.
28. Saulnier, N.; Lattanzi, W.; Puglisi, M. A.; Pani, G.; Barba, M.; Piscaglia, A. C.; Giachelia, M.; Alfieri, S.; Neri, G.; Gasbarrini, G.; Gasbarrini, A. Mesenchymal stromal cells multipotency and plasticity: Induction toward the hepatic lineage. Eur. Rev. Med. Pharmacol. Sci. 13(Suppl 1):71-78; 2009.
29. Smith, E. L.; Shmerling, R. H. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: Strengths, weaknesses, and opportunities for improvement. Lupus 8:586-595; 1999.
30. Sotiropoulou, P. A.; Perez, S. A.; Gritzapis, A. D.; Baxevanis, C. N.; Papamichail, M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74-85; 2006.
31. Stock, P.; Brückner, S.; Ebensing, S.; Hempel, M.; Dollinger, M. M.; Christ, B. The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver. Nat. Protoc. 5:617-627; 2010.
32. Sun, L.; Akiyama, K.; Zhang, H.; Yamaza, T.; Hou, Y.; Zhao, S.; Xu, T.; Le, A.; Shi, S. Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans. Stem Cells 27:1421-1432; 2009.
33. Sun, L.; Wang, D.; Liang, J.; Zhang, H.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Ye, S.; Hu, X.; Xu, W.; Zeng, X.; Hou, Y.; Gilkeson, G. S.; Silver, R. M.; Lu, L.; Shi, S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62:2467-2475; 2010.
34. Sun, L. Y.; Zhang, H. Y.; Feng, X. B.; Hou, Y. Y.; Lu, L. W.; Fan, L. M. Abnormality of bone marrow-derived mesenchymal stem cell in patients with systemic lupus erythematosus. Lupus 16:121-128; 2007.
35. Zhou, K.; Zhang, H.; Jin, O.; Feng, X.; Yao, G.; Hou, Y.; Sun, L. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell. Mol. Immunol. 5:417-424; 2008.